Statements in which the resource exists as a subject.
PredicateObject
rdf:type
lifeskim:mentions
pubmed:issue
Pt 2
pubmed:dateCreated
2002-5-23
pubmed:abstractText
Glycosylation of Asn-52 of the alpha-subunit (alphaAsn-52) is required for bioactivity of the alphabeta-dimeric human chorionic gonadotropin (hCG), although at a molecular level the effect of the glycan at alphaAsn-52 is not yet understood. To study the role of this glycan for heterodimer stability, the beta-subunit was recombined in solution with either the alpha-subunit or the alpha-subunit enzymically deglycosylated at alphaAsn-52. Enzymic deglycosylation avoids modification of the glycans at alphaAsn-78 and disturbing the protein folding. The efficiency of recombination after 16 h is 80%, independent of whether alphaAsn-52 is glycosylated or not. The dissociation constant of the hCG complex, with or without the glycan at alphaAsn-52, is less than 1 x 10(-5) s(-1), indicating that the glycan at alphaAsn-52 does not contribute significantly to the stability of the dimer. CD and NMR spectra indicate a local conformational difference between both alphabeta-dimeric hCG variants, most probably involving amino acids of the hCG beta-subunit close to the glycan at alphaAsn-52. These data explain the native-like receptor-binding abilities of hCG lacking the glycan at alphaAsn-52. It is proposed that for bioactivity the glycan at alphaAsn-52 is necessary for inducing and stabilizing a conformational change in hCG upon binding to the receptor, resulting in activation of the signal-transduction pathway.
pubmed:commentsCorrections
http://linkedlifedata.com/resource/pubmed/commentcorrection/12023892-10095786, http://linkedlifedata.com/resource/pubmed/commentcorrection/12023892-10446903, http://linkedlifedata.com/resource/pubmed/commentcorrection/12023892-10571021, http://linkedlifedata.com/resource/pubmed/commentcorrection/12023892-10821673, http://linkedlifedata.com/resource/pubmed/commentcorrection/12023892-10913841, http://linkedlifedata.com/resource/pubmed/commentcorrection/12023892-1200646, http://linkedlifedata.com/resource/pubmed/commentcorrection/12023892-1268193, http://linkedlifedata.com/resource/pubmed/commentcorrection/12023892-172504, http://linkedlifedata.com/resource/pubmed/commentcorrection/12023892-1820200, http://linkedlifedata.com/resource/pubmed/commentcorrection/12023892-2176077, http://linkedlifedata.com/resource/pubmed/commentcorrection/12023892-217642, http://linkedlifedata.com/resource/pubmed/commentcorrection/12023892-226790, http://linkedlifedata.com/resource/pubmed/commentcorrection/12023892-2311822, http://linkedlifedata.com/resource/pubmed/commentcorrection/12023892-2410022, http://linkedlifedata.com/resource/pubmed/commentcorrection/12023892-2502842, http://linkedlifedata.com/resource/pubmed/commentcorrection/12023892-2536708, http://linkedlifedata.com/resource/pubmed/commentcorrection/12023892-2732208, http://linkedlifedata.com/resource/pubmed/commentcorrection/12023892-2990039, http://linkedlifedata.com/resource/pubmed/commentcorrection/12023892-3190704, http://linkedlifedata.com/resource/pubmed/commentcorrection/12023892-3654620, http://linkedlifedata.com/resource/pubmed/commentcorrection/12023892-4415625, http://linkedlifedata.com/resource/pubmed/commentcorrection/12023892-5063546, http://linkedlifedata.com/resource/pubmed/commentcorrection/12023892-6267989, http://linkedlifedata.com/resource/pubmed/commentcorrection/12023892-6294091, http://linkedlifedata.com/resource/pubmed/commentcorrection/12023892-6309215, http://linkedlifedata.com/resource/pubmed/commentcorrection/12023892-6411645, http://linkedlifedata.com/resource/pubmed/commentcorrection/12023892-6426939, http://linkedlifedata.com/resource/pubmed/commentcorrection/12023892-7523203, http://linkedlifedata.com/resource/pubmed/commentcorrection/12023892-7544284, http://linkedlifedata.com/resource/pubmed/commentcorrection/12023892-7544493, http://linkedlifedata.com/resource/pubmed/commentcorrection/12023892-7922031, http://linkedlifedata.com/resource/pubmed/commentcorrection/12023892-8202136, http://linkedlifedata.com/resource/pubmed/commentcorrection/12023892-8885249, http://linkedlifedata.com/resource/pubmed/commentcorrection/12023892-8898911, http://linkedlifedata.com/resource/pubmed/commentcorrection/12023892-9027346, http://linkedlifedata.com/resource/pubmed/commentcorrection/12023892-9027347, http://linkedlifedata.com/resource/pubmed/commentcorrection/12023892-9099913, http://linkedlifedata.com/resource/pubmed/commentcorrection/12023892-9315876, http://linkedlifedata.com/resource/pubmed/commentcorrection/12023892-9578495
pubmed:language
eng
pubmed:journal
pubmed:citationSubset
IM
pubmed:chemical
pubmed:status
MEDLINE
pubmed:month
Jun
pubmed:issn
0264-6021
pubmed:author
pubmed:issnType
Print
pubmed:day
1
pubmed:volume
364
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
485-95
pubmed:dateRevised
2009-11-18
pubmed:meshHeading
pubmed:year
2002
pubmed:articleTitle
Studies on the relevance of the glycan at Asn-52 of the alpha-subunit of human chorionic gonadotropin in the alphabeta dimer.
pubmed:affiliation
Department of Bio-Organic Chemistry, Bijvoet Center, Utrecht University, P.O. Box 80.075, NL-3508 TB Utrecht, The Netherlands.
pubmed:publicationType
Journal Article, Research Support, Non-U.S. Gov't